Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11230
Title: Hepatitis a and e infection in international travellers.
Authors: Torresi, Joseph;Johnson, Douglas
Affiliation: Department of Infectious Diseases, Austin Center for Infection Research, Austin Hospital, Level 7, Harold Stokes Building, 145 Studley Road, Heidelberg, Victoria, 3084, Australia, josepht@unimelb.edu.au.
Issue Date: 1-Jun-2011
Citation: Current Infectious Disease Reports; 13(3): 248-55
Abstract: Hepatitis A is the most common vaccine-preventable infection in travellers. The incidence of hepatitis A for travellers ranges from 3.0 to 11.0 per 100,000 person-months and the case-fatality rate is as high as 2 per 100,000 in non-immune travellers. Hepatitis A vaccine is highly effective in preventing infection, significantly reducing the incidence of hepatitis A in travellers, and an important preventative intervention for the "last-minute" traveller. Hepatitis E virus is an important cause of enterically transmitted hepatitis in developing countries. The overall risk of hepatitis E in travellers visiting endemic countries is relatively low compared to hepatitis A. The majority of cases have been reported from the Indian subcontinent. The case fatality rate for hepatitis E is 1.2%, although this is substantially higher in pregnant women. A vaccine for hepatitis E is not available, and therefore travellers must be made aware of preventative measures to reduce their risk of infection.
Internal ID Number: 21424252
URI: http://ahro.austin.org.au/austinjspui/handle/1/11230
DOI: 10.1007/s11908-011-0179-7
URL: http://www.ncbi.nlm.nih.gov/pubmed/21424252
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
21424252.pdf55.68 kBAdobe PDFView/Open


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.